Pantec Biosolutions Granted European Patent for P.L.E.A.S.E
Pantec Biosolutions AG announced that it has been granted European Patent No. EP1874213, entitled ‘LASER MICROPORATOR’ by the European Patent Office. The patent, which was granted in September, covers the technology used in the company’s lead product P.L.E.A.S.E.® (Painless Laser Epidermal System) for creating micropores in the human skin prior to transdermal large molecular weight drug administration.
Thomas Bragagna, CTO of Pantec Biosolutions, commented: “We are delighted that Pantec has been granted this patent. After receiving CE marking and marketing clearance for P.L.E.A.S.E. last year, it is important for us to know that our key technology is now protected by patent laws.”
Pantec Biosolutions currently has an additional 19 applications pending in the USA, Europe and Japan. The Company plans to further develop its patent portfolio with the help of a well-balanced IP strategy in order to focus on current and future applications within the most important markets.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.